🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: BAY1817080

Found 14 matching trials

Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder (OAB)

PHASE2

The aim of the study is to determine how well the drug BAY1817080 works in ...

Status

Completed

Location

Emeritus Research

Start Date

2020-09-16

Trial ID

NCT04545580

Treatments Being Tested

Placebo BAY1817080

A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Participants (Part A). By Labeling BAY1817080 With a Radioactive Substance (Carbon 14) Researchers Want to Learn How the Study Drug is Processed and Excreted by the Body After Dosing (Part B)

PHASE1

Researchers are looking for a new way to treat people suffering either from...

Status

Completed

Location

PRAHealthSciences

Start Date

2020-08-05

Trial ID

NCT04487431

Treatments Being Tested

BAY1817080 [14C]BAY1817080

A Study in Healthy Volunteers Investigating How Quickly and to What Extent BAY1817080 is Taken up, Distributed, Broken Down and Eliminated From the Body, as Well as the Difference Between 2 Different Types of Tablets of BAY1817080 and the Difference Between Oral Dose and Dose in the Vein

PHASE1

The main purpose of this study is to investigate how quickly and to what ex...

Status

Completed

Location

PRAHealthSciences

Start Date

2018-12-13

Trial ID

NCT03773068

Treatments Being Tested

BAY1817080 - Formulation A BAY1817080 - Formulation B [13C715N]-BAY 181708 stable isotope label (SIL)

A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic Pain

PHASE2

People suffering from diabetes often have high blood sugar levels. Over tim...

Status

Terminated

Location

NEUROHK s.r.o

Start Date

2021-01-22

Trial ID

NCT04641273

Treatments Being Tested

BAY1817080 Placebo for BAY1817080 Placebo for Pregabalin Pregabalin

First in Human Study to Investigate the Safety and Tolerability, Pharmacokinetics, Itraconazole Drug-drug-interaction and Food Effect of BAY1817080

PHASE1

This study is a first in human study that will investigate the safety, tole...

Status

Completed

Location

CRS Clinical Research Services Berlin GmbH

Start Date

2016-07-22

Trial ID

NCT02817100

Treatments Being Tested

BAY1817080 Placebo Itraconazole

Repeat Doses of BAY 1817080 in Healthy Males & Proof of Concept in Chronic Cough Patients

PHASE1

To investigate the safety and tolerability of ascending repeated oral doses...

Status

Completed

Location

North Tyneside General Hospital

Start Date

2017-12-07

Trial ID

NCT03310645

Treatments Being Tested

BAY1817080 Matching Placebo

Study to Gather Information on the Influence of BAY1817080 on the Electrical Activity of the Heart Recorded by an Electrocardiogram in Healthy Male and Female Participants

PHASE1

In this study, researchers want to find whether the study drug BAY1817080 h...

Status

Completed

Location

CRS Clinical Research Services Mannheim GmbH

Start Date

2020-06-18

Trial ID

NCT04423744

Treatments Being Tested

BAY1817080 Moxifloxacin Placebo

Clinical Study to Evaluate the Efficacy and Safety of Three Different Doses of BAY1817080 Compared to Placebo in Patients With Chronic Cough

PHASE2

Researchers in this study want to find the optimal therapeutic dose of drug...

Status

Completed

Location

California Allergy & Asthma Medical Group & Research Center

Start Date

2020-10-02

Trial ID

NCT04562155

Treatments Being Tested

BAY1817080 Placebo

Study on the Safety of Drug BAY1817080 at Different Doses and the Way the Body Absorbs and Eliminates the Drug in Japanese Healthy Adult Male Participants

PHASE1

Researchers in this study want to learn about the safety of drug BAY1817080...

Status

Completed

Location

Hakata Clinic

Start Date

2020-02-15

Trial ID

NCT04265781

Treatments Being Tested

BAY1817080 Matching Placebo

Study on the Safety of BAY1817080 How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given to Participants With Moderate Renal Impairment and End Stage Renal Disease Requiring Dialysis Compared With Matched Participants With Normal Renal Function

PHASE1

BAY1817080 is currently under clinical development to treat pain related to...

Status

Completed

Location

Clinical Pharmacology of Miami, LLC

Start Date

2020-08-12

Trial ID

NCT04471337

Treatments Being Tested

BAY1817080

Previous Next